WELL:PA:PA-HAN-GINS Indxx Healthcare Megatrend Equal Weight UCITS ETF - Accumulating EUR (EUR)

ETF | Others |

Last Closing

USD 6.6741

Change

-0.05 (-0.72)%

Market Cap

N/A

Volume

111.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-02-12 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JPX4:PA Amundi Index Solutions - Amund..

-0.90 (-1.93%)

USD 55.36B
SPY5:PA SPDR® S&P 500 UCITS ETF EUR

-4.30 (-0.73%)

USD 14.29B
SP5C:PA Lyxor S&P 500 UCITS ETF - C-EU..

-3.15 (-0.75%)

USD 13.82B
WRD:PA HSBC MSCI World UCITS ETF

-0.24 (-0.65%)

USD 11.43B
MEUD:PA Amundi Stoxx Europe 600 UCITS ..

+0.34 (+0.13%)

USD 9.11B
EQQQ:PA Invesco EQQQ NASDAQ-100 UCITS ..

-3.70 (-0.72%)

USD 8.92B
WLD:PA Lyxor UCITS MSCI World D-EUR

-2.37 (-0.64%)

USD 7.99B
HHH:PA HSBC S&P 500 UCITS ETF

-0.44 (-0.75%)

USD 7.71B
LCWD:PA Multi Units Luxembourg - Lyxor..

-0.14 (-0.70%)

USD 6.91B
S500:PA Amundi S&P 500 ESG UCITS ETF A..

-1.11 (-0.67%)

USD 5.17B

ETFs Containing WELL:PA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 4.59% 65% D 61% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 4.59% 65% D 61% D-
Trailing 12 Months  
Capital Gain 0.52% 9% A- 38% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 0.52% 8% B- 37% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -0.42% 15% F 33% F
Dividend Return -0.42% 13% F 63% D
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 5.84% 85% B 94% A
Risk Adjusted Return -7.22% 13% F 62% D
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.